|
Re: Warrants conversion!
|
3
|
Resverlogix Corp.
|
Nov 26, 2019 11:01AM
|
|
Re: H1 2020 Potential Events
|
3
|
Resverlogix Corp.
|
Mar 01, 2020 10:11PM
|
|
Re: Warrant incentive program....
|
3
|
Resverlogix Corp.
|
Feb 05, 2020 05:18PM
|
|
Re: Where is the bottom?
|
3
|
Resverlogix Corp.
|
Dec 12, 2019 11:50AM
|
|
Re: ACC 2019 Abstracts
|
3
|
Resverlogix Corp.
|
Mar 04, 2019 03:40PM
|
|
Re: eGFR data question from IR
|
3
|
Resverlogix Corp.
|
Nov 26, 2019 05:20PM
|
|
Re: MACE Event rate,....
|
3
|
Resverlogix Corp.
|
Mar 01, 2019 05:05PM
|
|
Re: Reata, Bardoxolone, NRF2, CKD, Mitochondria, Inflammation, Redox Balance, Reactive Oxygen Species
|
3
|
Resverlogix Corp.
|
Jun 14, 2019 11:23AM
|
|
Re: A hunch about the below median LDL-C observation
|
3
|
Resverlogix Corp.
|
Nov 20, 2019 03:31PM
|
|
Re: EDITRe: i would love to hear,..
|
3
|
Resverlogix Corp.
|
Dec 06, 2019 04:52PM
|
|
Re: A hunch about the below median LDL-C observation
|
3
|
Resverlogix Corp.
|
Nov 20, 2019 03:44PM
|
|
Re: ACC 2019 Abstracts
|
3
|
Resverlogix Corp.
|
Mar 04, 2019 11:04PM
|
|
Re: Question to ask at the AGM
|
3
|
Resverlogix Corp.
|
Oct 31, 2019 01:35PM
|
|
Re: BRD2 involvement in Covid19
|
3
|
Resverlogix Corp.
|
Mar 18, 2020 12:40PM
|
|
Re: RVX-297 vs RVX-208 for autoimmune indications
|
3
|
Resverlogix Corp.
|
Jan 09, 2019 01:07PM
|
|
Re: BRD2 involvement in Covid19
|
3
|
Resverlogix Corp.
|
Mar 18, 2020 01:10PM
|
|
Re: Angiotensin and Coronavirus
|
3
|
Resverlogix Corp.
|
Mar 23, 2020 10:20PM
|
|
Re: RVX-297 vs RVX-208 for autoimmune indications
|
2
|
Resverlogix Corp.
|
Jan 09, 2019 04:16PM
|
|
Re: Contest
|
2
|
Resverlogix Corp.
|
Sep 16, 2019 01:32PM
|
|
Re: RESVERLOGIX ANNOUNCES WARRANT EXERCISE INCENTIVE PROGRAM
|
2
|
Resverlogix Corp.
|
Nov 25, 2019 06:50PM
|
